Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Can Investors Leverage Leftover Skepticism On Genworth To Their Advantage?

A few years ago investors were spoiled for choice when it came to insurance companies. Many of these companies have since repaired their balance sheets and returned to posting decent if not good returns. The markets have responded, leaving investors considering names like MetLife (NYSE:MET) and Arch Capital (NASDAQ:ACGL) in a position where they are looking at longer timelines for meaningful market-beating returns.

Genworth (NYSE:GNW) is a different story. The stock has given investors a wild ride, but the last couple of years have been pretty solid. Even with new management and clear progress in improving its businesses, there's still some lingering skepticism regarding Genworth and the company's ability to return to high single-digit...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details